Health
Study: Thymoquinone selectively kills prostate cancer cells at advanced stages – News-Medical.Net
The compound thymoquinone (TQ) selectively kills prostate cancer cells at advanced stages, according to a new study published in Oncogene.
Reviewed by Emily Henderson, B.Sc.Oct 8 2020
The compound thymoquinone (TQ) selectively kills prostate cancer cells at advanced stages, according to a new study published in Oncogene. Led by researchers at Kanazawa University, the study reports that prostate cancer cells with a deletion of the SUCLA2 gene can be therapeutically targeted.
SUCLA2-deficient prostate cancers represent a significant fraction of those resistant to hormone therapy or metastatic, and a new therapeutic option for this …
-
General17 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire
-
Business23 hours ago3 of the best ASX ETFs for beginners to buy with $1,000
-
Noosa News22 hours agoToyah Cordingley’s accused killer ‘3.7 billion times more likely than not’ to have contributed to DNA sample near burial site, court told
-
Business21 hours agoWhy this ASX 200 tech stock could rise 20%